Transplant drugs may help wipe out persistent HIV infections

April 3, 2014

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS.

Despite the effectiveness of antiviral therapies at suppressing HIV, the virus still persists indefinitely at low levels in infected patients who are diligent about taking their medications. "Current therapies fail to cure the disease as they do not attack those viruses that remain hidden within the immune system," said Steven Deeks, MD, of the University of California, San Francisco. Researchers suspect that inflammation in the body in response to HIV infection may create an environment that supports this viral persistence.

Dr. Deeks and his colleagues wondered whether immunosuppressant therapy could reduce such inflammation and therefore help defeat HIV. To investigate, the team looked at how HIV infection is affected by immunosuppressants that are commonly taken by to reduce their risk of rejection. The analysis included 91 recipients who were followed for a median of 3.2 years post-transplant.

When the investigators analyzed blood samples from the study participants, they found that HIV remained well-controlled following transplantation and long-term exposure to . Importantly, they also discovered that patients who took a particular called sirolimus as part of their treatment regimen had fewer cells in their blood that were infected with HIV over time. The findings suggest that immune-modifying drugs such as sirolimus may affect the level of HIV persistence. "Based on the observations in this study, the NIH is now sponsoring a targeted study to see if sirolimus might indeed contribute to a cure of HIV infection," said Dr. Deeks.

Dr. Deeks, who is an HIV researcher and clinician, noted that the work was done in collaboration with UCSF transplant surgeons led by Peter Stock, MD, PhD, and study coordinator Rodney Rogers. "Our study highlights the potential synergies that can occur when two very different disciplines merge their talents and resources," said Dr. Deeks. "We feel that the transplant community has much to teach the HIV community about the potential role of strong immune-suppressing drugs in curing HIV disease."

The results come only several months after the federal government passed legislation—called the HIV Organ Transplant Equity (HOPE) Act—to end the federal ban on the transplantation of HIV-positive organs to patients with HIV.

Explore further: HIV can infect transplanted kidneys in HIV-positive recipients with undetectable virus

More information: "Reduction of HIV Persistence Following Transplantation in HIV Infected Kidney Transplant Recipients." Peter G. Stock, Burc Barin, Hiroyu Hatano, Rodney L. Rogers, Michelle E. Roland, Tzong-Hae Lee, Michael Busch, and Steven G. Deeks, for the Solid Organ Transplantation in HIV Study Investigators. American Journal of Transplantation; Published Online: April 3, 2014. DOI: 10.1111/ajt.12699

Related Stories

HIV can infect transplanted kidneys in HIV-positive recipients with undetectable virus

December 5, 2013
HIV can infect transplanted kidneys in HIV-positive recipients even in the absence of detectable virus in the blood, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology ...

HIV treatment while incarcerated helped prisoners achieve viral suppression

March 31, 2014
Treating inmates for the human immunodeficiency virus (HIV) while they were incarcerated in Connecticut helped a majority of them achieve viral suppression by the time they were released.

HIV no barrier to getting liver transplant, study finds

May 17, 2013
(HealthDay)—Liver transplants to treat a common type of liver cancer are a viable option for people infected with HIV, according to new research.

Study identifies population of stem-like cells where HIV persists in spite of treatment

January 12, 2014
Although antiviral therapy against HIV suppresses viral replication and allows infected individuals to live relatively healthy lives for many years, the virus persists in the body, and replication resumes if treatment is ...

Mayo Clinic makes kidney and pancreas transplant available to HIV-infected patients

December 6, 2011
Mayo Clinic in Florida is now offering kidney and pancreas transplants to HIV positive patients with advanced kidney disease and diabetes. Evidence is now solid that HIV-positive patients have the same favorable outcome in ...

HIV-infected donors present novel source of organs for HIV-infected transplant candidates

May 23, 2011
A new study published in the American Journal of Transplantation reveals that HIV-infected deceased donors represent a potentially novel source of organs for HIV-infected transplant candidates that could decrease waitlist ...

Recommended for you

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

Mathematical modeling uncovers mysteries of HIV infection in the brain

June 19, 2017
After uncovering the progression of HIV infection in the brain thanks to a new mathematical model developed by a UAlberta research team, clinicians and researchers are developing a nasal spray to administer drugs more effectively.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.